agilon health (NYSE:AGL) Price Target Raised to $3.00

agilon health (NYSE:AGL) had its target price hoisted by investment analysts at Stifel Nicolaus from $2.00 to $3.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The brokerage presently has a “hold” rating on the stock. Stifel Nicolaus’ price objective would indicate a potential downside of 10.42% from the stock’s previous close.

A number of other equities analysts have also weighed in on AGL. Royal Bank of Canada reiterated an “outperform” rating and issued a $3.00 price target on shares of agilon health in a research report on Tuesday, November 19th. Citigroup raised shares of agilon health from a “sell” rating to a “neutral” rating and raised their price objective for the stock from $1.75 to $2.25 in a research note on Friday, January 10th. Needham & Company LLC reissued a “hold” rating on shares of agilon health in a research note on Wednesday. Macquarie assumed coverage on agilon health in a report on Monday, December 16th. They issued a “neutral” rating and a $3.00 target price for the company. Finally, TD Cowen dropped their price target on agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a research report on Monday, November 11th. Two investment analysts have rated the stock with a sell rating, fourteen have issued a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $4.10.

agilon health Price Performance

NYSE AGL opened at $3.35 on Wednesday. The stock has a market capitalization of $1.38 billion, a P/E ratio of -3.37 and a beta of 0.66. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. The business’s fifty day moving average is $2.89 and its two-hundred day moving average is $3.04. agilon health has a 1 year low of $1.50 and a 1 year high of $7.73.

Insider Buying and Selling

In other news, Director Karen Mcloughlin acquired 25,000 shares of the stock in a transaction on Friday, December 13th. The shares were purchased at an average price of $2.20 per share, for a total transaction of $55,000.00. Following the transaction, the director now directly owns 73,166 shares of the company’s stock, valued at approximately $160,965.20. This represents a 51.90 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director John William Wulf purchased 45,000 shares of the stock in a transaction that occurred on Thursday, December 5th. The shares were acquired at an average cost of $2.18 per share, for a total transaction of $98,100.00. Following the completion of the transaction, the director now owns 206,133 shares of the company’s stock, valued at $449,369.94. This trade represents a 27.93 % increase in their position. The disclosure for this purchase can be found here. In the last three months, insiders have acquired 77,500 shares of company stock valued at $169,600. 3.20% of the stock is owned by insiders.

Institutional Trading of agilon health

Institutional investors have recently modified their holdings of the stock. Los Angeles Capital Management LLC acquired a new position in shares of agilon health in the 3rd quarter valued at approximately $513,000. Aigen Investment Management LP acquired a new stake in shares of agilon health in the 3rd quarter valued at $79,000. Simplify Asset Management Inc. increased its stake in shares of agilon health by 67.5% in the 3rd quarter. Simplify Asset Management Inc. now owns 168,696 shares of the company’s stock valued at $663,000 after purchasing an additional 67,968 shares during the last quarter. Intech Investment Management LLC bought a new stake in shares of agilon health during the 3rd quarter worth $228,000. Finally, Citigroup Inc. boosted its stake in agilon health by 2,251.5% in the third quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock valued at $7,971,000 after buying an additional 1,941,993 shares in the last quarter.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.